<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Camp ND</submitter><funding>Howard Hughes Medical Institute</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>6539-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3307315</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>287(9)</volume><pubmed_abstract>WTX is a tumor suppressor protein that is lost or mutated in up to 30% of cases of Wilms tumor. Among its known functions, WTX interacts with the β-transducin repeat containing family of ubiquitin ligase adaptors and promotes the ubiquitination and degradation of the transcription factor β-catenin, a key control point in the WNT/β-catenin signaling pathway. Here, we report that WTX interacts with a second ubiquitin ligase adaptor, KEAP1, which functions to regulate the ubiquitination of the transcription factor NRF2, a key control point in the antioxidant response. Surprisingly, we find that unlike its ability to promote the ubiquitination of β-catenin, WTX inhibits the ubiquitination of NRF2. WTX and NRF2 compete for binding to KEAP1, and thus loss of WTX leads to rapid ubiquitination and</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein.</pubmed_title><pmcid>PMC3307315</pmcid><funding_grant_id>R01 CA107134</funding_grant_id><funding_grant_id>R00 HL103768</funding_grant_id><funding_grant_id>T32 GM07270</funding_grant_id><funding_grant_id>T32 GM007270</funding_grant_id><pubmed_authors>Davison JM</pubmed_authors><pubmed_authors>Zheng N</pubmed_authors><pubmed_authors>Major MB</pubmed_authors><pubmed_authors>James RG</pubmed_authors><pubmed_authors>Moon RT</pubmed_authors><pubmed_authors>Dawson DW</pubmed_authors><pubmed_authors>Houck SA</pubmed_authors><pubmed_authors>Camp ND</pubmed_authors><pubmed_authors>Yan F</pubmed_authors><pubmed_authors>Tang X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein.</name><description>WTX is a tumor suppressor protein that is lost or mutated in up to 30% of cases of Wilms tumor. Among its known functions, WTX interacts with the β-transducin repeat containing family of ubiquitin ligase adaptors and promotes the ubiquitination and degradation of the transcription factor β-catenin, a key control point in the WNT/β-catenin signaling pathway. Here, we report that WTX interacts with a second ubiquitin ligase adaptor, KEAP1, which functions to regulate the ubiquitination of the transcription factor NRF2, a key control point in the antioxidant response. Surprisingly, we find that unlike its ability to promote the ubiquitination of β-catenin, WTX inhibits the ubiquitination of NRF2. WTX and NRF2 compete for binding to KEAP1, and thus loss of WTX leads to rapid ubiquitination and</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Feb</publication><modification>2025-04-18T13:57:42.542Z</modification><creation>2019-03-27T00:51:21Z</creation></dates><accession>S-EPMC3307315</accession><cross_references><pubmed>22215675</pubmed><doi>10.1074/jbc.M111.316471</doi></cross_references></HashMap>